Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 33 pages
Exam (elaborations)

NCLEX-RN Pharmacology Neurological System Part 1 Exam Questions with Rationales | 20 ATI & NGN-Style Practice MCQs

Document preview thumbnail
Preview 4 out of 33 pages

NCLEX-RN Pharmacology Neurological System Part 1 Exam Questions with Rationales | 20 ATI & NGN-Style Practice MCQs Master neurological pharmacology with this comprehensive NCLEX-RN study resource featuring 20 original ATI and Next Generation NCLEX (NGN)-style multiple-choice questions. Topics include Parkinson disease medications, anticonvulsants, benzodiazepines, Alzheimer disease drugs, medication safety, adverse effects, drug interactions, patient teaching, contraindications, laboratory monitoring, and priority nursing interventions. Each question includes detailed rationales, clinical judgment applications, learning objectives, and medication safety concepts to strengthen exam readiness and nursing pharmacology knowledge. NCLEX Pharmacology Neurological Pharmacology ATI Pharmacology Made Easy NGN NCLEX Practice Questions Nursing Pharmacology Exam Parkinson Disease Medications Anticonvulsant Drugs Nursing

Content preview

NCLEX-RN Pharmacology Neurological
System Part 1
20 NGN-Style Practice Questions with
Rationales
Nursing Exam Prep 2026


Question 1
Clinical Scenario
A 68-year-old client with Parkinson disease is prescribed
carbidopa/levodopa. During a follow-up visit, the client reports
improved mobility but states, “My urine has become dark
brown, and I'm worried something is wrong.”
Question Stem
Which response by the nurse is most appropriate?
A. "Stop taking the medication and contact the provider
immediately."
B. "This finding may indicate kidney failure."

,C. "Dark urine can occur with this medication and is usually
harmless."
D. "You should increase your fluid intake to reverse this effect."
Correct Answer
Correct Answer: C. "Dark urine can occur with this medication
and is usually harmless."
Detailed Rationale
Carbidopa/levodopa is the cornerstone treatment for Parkinson
disease. Levodopa crosses the blood-brain barrier and is
converted to dopamine, while carbidopa reduces peripheral
conversion and adverse effects. A harmless but often alarming
side effect is darkening of urine, sweat, or saliva.
Option C is correct because this is an expected effect that
should be included in patient education. Reassurance helps
promote medication adherence and reduces unnecessary
discontinuation.
Option A is incorrect because dark urine alone is not an
indication to stop therapy. Abrupt discontinuation may worsen
Parkinson symptoms and can precipitate severe complications.
Option B is incorrect because dark urine associated with
levodopa is not evidence of kidney failure. Renal dysfunction
would require additional findings such as elevated creatinine or
reduced urine output.

,Option D is incorrect because increased fluids do not reverse
medication-induced discoloration and are not the priority
teaching point.
Nurses should educate clients about expected effects, monitor
therapeutic response, and assess for dyskinesias, orthostatic
hypotension, and hallucinations.
Learning Objective
After completing this question, the learner should be able to:
• Identify common adverse effects of carbidopa/levodopa.
• Provide accurate patient teaching regarding expected
medication effects.
• Promote medication adherence through education.
• Differentiate harmless side effects from serious adverse
reactions.
Medication Safety Focus
Patient education


Question 2
Clinical Scenario
A 74-year-old client with Parkinson disease takes
carbidopa/levodopa three times daily. The nurse notes the

, client received a high-protein breakfast immediately before the
morning dose.
Question Stem
Which outcome is most likely if the medication is taken with a
high-protein meal?
A. Increased medication absorption
B. Reduced therapeutic effect of levodopa
C. Increased risk for hypertensive crisis
D. Development of serotonin syndrome
Correct Answer
Correct Answer: B. Reduced therapeutic effect of levodopa
Detailed Rationale
Levodopa competes with dietary amino acids for transport
across the intestinal wall and blood-brain barrier. High-protein
meals can significantly decrease absorption and availability of
levodopa, reducing symptom control.
Option B is correct because diminished absorption may lead to
worsening tremors, rigidity, and bradykinesia.
Option A is incorrect because protein decreases—not
increases—levodopa effectiveness.

Document information

Uploaded on
July 21, 2026
Number of pages
33
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$22.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
4
Followers
1
Items
274
Last sold
2 weeks ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions